Interleukin-18 Antagonism Improved Histopathological Conditions of Malaria Infection in Mice

Marzieh Jabbarzare1, Voon Kin Chin2, Herni Talib3

  • 1Dept. of Human Anatomy, Faculty of Medicine & Health Sciences, Universiti Putra Malaysia, Selangor, Malaysia.

Abstract

Insights

Modulating Interleukin 18 (IL-18) significantly improved organ damage in malaria-infected mice. Targeting IL-18 shows promise for treating malaria pathogenesis and protecting hosts.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Pathology

Background:

  • Interleukin 18 (IL-18) has diverse roles in inflammatory diseases.
  • Its specific role in malaria pathogenesis remains unclear.
  • Previous research suggests IL-18 modulation has therapeutic potential.

Purpose of the Study:

  • To investigate the effect of IL-18 modulation on malaria-induced histopathology.
  • To establish the role of IL-18 in malaria infection.

Main Methods:

  • A Plasmodium berghei ANKA mouse model of malaria was utilized.
  • Mice were treated with recombinant mouse IL-18 (rmIL-18) and rmIL-18Fc.
  • Histopathological analysis was conducted on major organs (brain, liver, spleen, lungs, kidney).

Main Results:

  • Treatment with rmIL-18Fc significantly ameliorated histopathological damage in organs of malaria-infected mice.
  • This indicates a protective effect of rmIL-18Fc against malaria-induced organ injury.

Conclusions:

  • Interleukin 18 (IL-18) plays a crucial role in malaria pathogenesis.
  • Targeting IL-18 presents a potential therapeutic strategy for malaria-infected individuals.